Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Analytical Biochemistry, 1(441), p. 87-94, 2013

DOI: 10.1016/j.ab.2013.05.035

Links

Tools

Export citation

Search in Google Scholar

A colorimetric assay optimization for high-throughput screening of dihydroorotase by detecting ureido groups

Journal article published in 2013 by Amy J. Rice, Lena Truong, Michael E. Johnson ORCID, Hyun Lee ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Dihydroorotase (DHOase) is the third enzyme in the de novo pyrimidine biosynthesis pathway, and a potential new antibacterial drug target. No target-based high-throughput screening (HTS) assay for this enzyme has been reported to date. Here, we optimized two colorimetric-based enzymatic assays that detect the ureido moiety of the DHOase substrate, carbamyl-aspartate (Ca-asp). Each assay was developed in a 40 μL assay volume using 384-well plates with a different color mix, diacetylmonoxime (DAMO)/thiosemicarbazide (TSC) or DAMO/antipyrine. The sensitivity and color interference of both color mixes were compared in the presence of common HTS buffer additives includingdimethyl sulfoxide (DMSO), reducing agents, detergents, and bovine serum albumin (BSA). DAMO-TSC (z'-factors 0.7-0.8) was determined to be superior to DAMO-antipyrine (z'-factors 0.5-0.6) with significantly less variability within replicates. A HTS pilot screening with 29,552 compounds from four structurally diverse libraries confirmed the quality of our newly optimized colorimetric assay with DAMO-TSC. This robust method has no heating requirement which was the main obstacle of applying previous assays to HTS. More importantly, this well-optimized HTS assay for DHOase, the first of its kind, should make it possible to screen large scale compound libraries to develop new inhibitors against any enzymes that produce ureido functional groups.